{"url_path":"/sec/cdio/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1870144/0001553350-26-000089-index.html","accession_number":"0001553350-26-000089","cik":"0001870144","ticker":"CDIO","issuer_name":"Cardio Diagnostics Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1870144/0001553350-26-000089-index.html","primary_entity_key":"0001870144","primary_entity_name":"Cardio Diagnostics Holdings, Inc."},"word_count":45,"has_tables":true,"body_markdown":"**ITEM 5. OTHER INFORMATION**\n\n \n\nNone of the\nCompany’s directors or officers adopted, modified or terminated a Rule 10b-5 trading arrangement or a non-Rule 10b-5 trading arrangement\nduring the fiscal quarter ended March 31, 2026, as such terms are defined under Item 408(a) of Regulation S-K."}